N-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas

NCT07049432 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Drug Unavailable

Conditions

B-cell Non Hodgkin Lymphoma

Interventions

DRUG: N803

Sponsor

University of Utah

Collaborators

[object Object]